Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for FMS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 1999. Start Trial.
Date Value
June 30, 2026 168.89M
March 31, 2026 406.35M
December 31, 2025 492.79M
September 30, 2025 170.29M
June 30, 2025 0.00
March 31, 2025 0.00
December 31, 2024 0.00
September 30, 2024 0.00
June 30, 2024 0.00
March 31, 2024 0.00
December 31, 2023 0.00
September 30, 2023 0.00
June 30, 2023 0.00
March 31, 2023 0.00
December 31, 2022 0.6575M
September 30, 2022 0.5287M
June 30, 2022 -21.29M
March 31, 2022 -0.8908M
December 31, 2021 -0.499M
September 30, 2021 -0.9143M
June 30, 2021 -5.608M
March 31, 2021 -0.6944M
December 31, 2020 8.155M
September 30, 2020 4.138M
June 30, 2020 151.88M
Date Value
March 31, 2020 237.72M
December 31, 2019 135.76M
September 30, 2019 188.58M
June 30, 2019 224.13M
March 31, 2019 101.32M
December 31, 2018 -3.468M
September 30, 2018 -46.88M
June 30, 2018 38.98M
March 31, 2018 -0.6892M
December 31, 2017 -10.03M
September 30, 2017 -7.289M
June 30, 2017 -31.27M
March 31, 2017 -4.705M
December 31, 2016 -5.084M
September 30, 2016 -26.63M
June 30, 2016 -18.51M
March 31, 2016 -2.544M
December 31, 2015 -26.93M
September 30, 2015 -13.47M
June 30, 2015 -37.31M
March 31, 2015 -16.45M
December 31, 2014 -19.42M
September 30, 2014 -45.17M
June 30, 2014 -35.29M
March 31, 2014 -5.943M

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
DaVita, Inc. 360.82M
Rhön-Klinikum AG 0.00
FamiCord AG 0.00
Quest Diagnostics, Inc. 86.00M
Acadia Healthcare Co., Inc. 3.807M